1Robertson JS, Nicolsen C, Newman R, et al. High growth reassortant influenza vaccine viruses: New approaches to their control. Biologicals,1992,20:213-220.
2Wareing MD, Tannock GA. Live attenuated vaccines against influenza;an historical review. Vaccine, 2001,19: 3320-3330.
3Tolpin MD, Massicot JG, Mullinix MG, et al. Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-lA2 recombinant during growth in vivo. Virology, 1981,112:505-517.
4Be are AS, Schild GC, Craig JW. Trials in man with live recombinants made from A/PR/8/34 (H1N1) and with H3N2 influenza viruses.Lancet, 1975,2: 729-732.
5Tre anor JJ, Tierney EL, London WT, et al. Characterisation of the attenuating M and NP gene segments of the avian influenza A/Mallard/78virus during in vitro production of avian-human reassortant vaccine viruses and after replication in humans and primat
6Klimov AI, Cox NJ, Yotov WV, et al. Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57(H2N2) virus. Virology, 1992,186: 795-797.
7Beyer WE, PalacheAM, de Jong JC, et al. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine; efficacy. A meta-analysis.Vaccine, 2002,20 ( 9-10 ): 1340-1353.
8Cha TA, Kao K, Zhao J, et al. Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial. J Clin Microbiol,2000,38: 839-845.
9Kemble G, Greenberg H. Novel generations of influenza vaccines. Vaccine, 2003,21:1789-1795.
10Romanova JR, Tannock GA, Alexandrova GI. Protective responses in mice to vaccination with multiply administered cold-adapted influenza vaccine reassortants and wild-type viruses. Vaccine, 1997,15:653-658.
3Seo S H,Hoffmann E,Webster R G.Lethal H5N1 influenza viruses escape host anti-viral cytokine responses[J].Nat Med,2002,8:950-954.
4Maassab H F,DeBorde D C.Characterization of an influenza A host range mutant[J].Virology,1983,130:342-350.
5Snyder M H,London W T,Maassab H F,et al.A 36 nucleotide deletion mutation in the coding region of the NS1 gene of an influenza A virus RNA segment 8 specifies a temperature-dependent host range phenotype[J].Virus Res,1990,15:69-83.
6Bruhl P,Kerschbaum A,Kistner O,et al.Humoral and cell-mediated immunity to Vero cell-derived influenza vaccine[J].Vaccine,2000,19:1149-1158.
7Kida H,Brown L E,Webster R G.Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus[J].Virology,1982,122:38-47.
8Fortes P,Beloso A,Ortin J.Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport[J].EMBO J,1994,13:704-712.
9Bullido R,Gomez-Puertas P,Saiz M J,et al.Influenza A virus NEP (NS2 protein) down regulates RNA synthesis of model template RNAs[J].J Virol,2001,75:4912-4917.
10Qiu Y,Nemeroff M.Krug R M.The influenza virus NS1 protein binds to a specific region in human U6 snRNA and inhibits U6-U2 and U6-U4 snRNA interactions during splicing[J].RNA,1995,1:304-316.
